Status: Not yet recruiting
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
This clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophageal, cervical, cutaneous).
Participants needed: 132
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: InduPro, Inc.Updated: May 22, 2026Locations: 1
Eligibility criteria
Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 [+7]
Any clinically significant cardiac disease [+21]